Species heterogeneity between gerbils and rats: Quinolinate production by microgila and astrocytes and accumulations in response to ischemic brain injury and systemic immune activation

Journal of Neurochemistry

Volumn 69, Issue 4, 1997, Pages 1519-1529

  Heyes, Melvyn P ^a   Saito, Kuniaki ^d   Chen, Cai Y ^a   Proescholdt, Margit G ^a   Nowak Jr , Thaddeus S ^c   Li, Ju ^c   Beagles, Karen E ^a   Proescholdt, Martin A ^b   Zito, Mark A ^a   Kawai, Kensuke ^e   Markey, Sanford P ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^c UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^d GIFU UNIVERSITY   (Japan)

^e UNIVERSITY OF TOKYO   (Japan)

Author keywords

Astrocytes; Endotoxin; Gerbil; Immune activation; Ischemic brain injury; Kynurenine pathway; Microglia; Rat; Species differences

Indexed keywords

ENDOTOXIN; KYNURENINE; LIPOPOLYSACCHARIDE; NEUROTOXIN; QUINOLINIC ACID; TRYPTOPHAN 2,3 DIOXYGENASE;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; ASTROCYTE; BRAIN DISEASE; BRAIN ISCHEMIA; CONTROLLED STUDY; GERBIL; HIPPOCAMPUS; IMMUNE SYSTEM; MICROGLIA; NONHUMAN; PRIORITY JOURNAL; RAT; SPECIES DIFFERENCE;

ANIMALIA; GERBILLINAE;

EID: 0030930823     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1997.69041519.x     Document Type: Article

References (69)

1. Antanitus D. S., Choi B. H., and Lapham L. W. (1975) Immunofluorescence staining of astrocytes in vitro using antiserum to glial fibrillary acidic protein. Brain Res. 98, 363-367.
2. Barratte S., Molinari A., Veneroni O., Dho L., Speciale C., Benatti L., and Salvati P. (1996) Temporal and spatial changes of quinolinic acid immunoreactivity in the hippocampus following transient forebrain ischemia. Soc. Neurosci. Abstr. 22, 1795.
3. Basile A. S., Saito K., Li Y., and Heyes M. P. (1995) The relationship between plasma and brain quinolinic acid levels and the severity of hepatic encephalopathy in animal models of fulminant hepatic failure. J. Neurochem. 64, 2607-2614.
4. Blight A. R., Saito K., and Heyes M. P. (1993) Increased levels of the excitotoxin quinolinic acid in spinal cord following contusion injury. Brain Res. 632, 314-316.
5. Blight A. R., Cohen T. I., Saito K., and Heyes M. P. (1995) Quinolinic acid accumulation and functional deficits following experimental spinal cord injury. Brain 118, 735-752.
6. Blight A. R., LeRoy E. C., and Heyes M. P. (1997) Quinolinic acid synthesis in injured spinal cord: timecourse, distribution and species differences between rat and guinea pig. J. Neurotrauma 14, 89-98.
7. Brint S., Jacewicz M., Kiessling M., Tanabe J., and Pulsinelli W. (1988) Focal brain ischemia in the rat: methods for reproducible neocortical infarction using tandem occlusion of the distal middle cerebral and ispilateral common carotid arteries. J. Cereb. Blood Flow Metab. 8, 474-485.
8. Cook J. S., Pogson C. I., and Smith S. A. (1980) Indoleamine 2,3-dioxygenase. A new, rapid, sensitive radiometric assay and its application to the study of the enzyme in rat tissues. Biochem. J. 189, 461-466.
9. Daley-Yates P. T., Powell A. P., and Smith L. L. (1988) Pulmonary indoleamine 2,3 dioxygenase activity and its significance in the responses of rats, mice, and rabbits to oxidative stress. Toxicol. Appl. Pharmacol. 96, 222-232.
10. Dietrich W. D., Lin B., Globus M. Y.-T., Green E., Kraydieh S., Ginsberg M., and Busto R. (1995) Effect of delayed MK-801 treatment with or without immediate postischemic hypothermia on chronic neuronal survival after global forebrain ischemia in rats. (Abstr.) J. Cereb. Blood Flow Metab. 15 (Suppl. 1), S239.
11. Dugas B., Mossalayi M. D., Damais C., and Kolb J.-P. (1995) Nitric oxide production by human monocytes: evidence for a role of CD23. Immunol. Today 16, 574-580.
12. Endoh M., Maiese K., Pulsinelli W. A., and Wagner J. A. (1993) Reactive astrocytes express NADPH diaphorase in vivo after transient ischemia. Neurosci. Lett. 154, 125-128.
13. Espey M. G., Reinhard J. F., Chernyshev O. N., Colton C., and Namboodiri M. A. A. (1996) Determination of quinolinic acid synthesis in human astrocytes and microglia in vitro. Soc. Neurosci. Abstr. 22, 1908.
14. Flanagan E. M., Erickson J. B., Viveros O. H., Chang S. Y., and Reinhard J. F. Jr. (1995) Neurotoxin quinolinic acid is selectively elevated in spinal cords of rats with experimental allergic encephalomyelitis. J. Neurochem. 64, 1192-1196.
15. Giulian D. and Baker T. J. (1985) Peptides released by ameboid microglia regulate astroglial proliferation. J. Cell Biol. 101, 2411-2415.
16. Giulian D., Baker T. J., Shih L, C., and Lachman L. B. (1986) Interleukin 1 of the central nervous system is produced by ameboid microglia. J. Exp. Med. 164, 594-604.
17. Härtl R., Schürer L., Schmid-Schonbein G. W., and del Zoppo G. J. (1996) Experimental antileukocyte interventions in cerebral ischemia. J. Cereb. Blood Flow Metab. 16, 1108-1119.
18. Haycock K. A., Roth J., Gagnon J., Finzer W. F., and Soper C. (1992) Statview. Abacus Concepts, Berkley, California.
19. Herscowitz H. B., Tolden H. T., Bellanti J. A., and Ghaffar A. (1981) Manual of Macrophage Methodology: Collection, Characterization and Function. Marcel Dekker, New York.
20. Heyes M. P. and Lackner A. (1990) Increased cerebrospinal fluid quinolinic acid, kynurenic acid, and L-kynurenine in acute septicemia. J. Neurochem. 55, 338-341.
21. Heyes M. P. and Markey S. P. (1988) Quantification of quinolinic acid in rat brain, whole blood and plasma by gas chromatography and negative chemical ionization mass spectrometry: effects of systemic L-tryptophan administration on brain and blood quinolinic acid concentrations. Anal. Biochem. 174, 349-359.
22. Heyes M. P. and Morrison P. F. (1997) Quantification of local de novo synthesis versus blood contributions to quinolinic acid concentrations in brain and systemic tissues. J. Neurochem. 68, 280-288.
23. Heyes M. P., Quearry B. J., and Markey S. P. (1989) Systemic endotoxin increases L-tryptophan, 5-hydroxyindoleacetic acid. 3-hydroxykynurenine and quinolinic acid content of mouse cerebral cortex. Brain Res. 491, 173-179.
24. Heyes M. P., Papagapiou M., Leonard C., Markey S. P., and Auer R. N. (1990) Brain and plasma quinolinic acid in profound insulin-induced hypoglycemia. J. Neurochem. 54, 1027-1033.
25. Heyes M. P., Saito K., Crowley J., Davis L. E., Demitrak M. A., Der M., Dilling L., Kruesi M. J. P., Lackner A., Larsen S. A., Lee K., Leonard H., Markey S. P., Martin A., Milstien S., Mouradian M. M., Pranzatelli M. R., Quearry B. J., Salazar A., Smith M., Straus S. E., Sunderland T., Swedo S., and Tourtellotte W. W. (1992a) Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurologic disease. Brain 115, 1249-1273.
26. Heyes M. P., Saito K., Jacobowitz D., Takikawa O., Markey S. P., and Vickers J. (1992b) Poliovirus induces indoleamine-2,3-dioxygenase and quinolinic acid synthesis in macaque brain. FASEB J. 6, 2977-2989.
27. Heyes M. P., Saito K., and Markey S. P. (1992c) Human macrophages convert L-tryptophan to the neurotoxin quinolinic acid. Biochem. J. 283, 633-635.
28. Heyes M. P., Saito K., Major E. O., Milstien S., Markey S. P., and Vickers J. H. (1993) A mechanism of quinolinic acid formation by brain in inflammatory neurologic disease: attenuation of synthesis from L-tryptophan by 6-chloro-tryptophan and 4-chloro-3-hydroxyanthranilate. Brain 116, 1425-1450.
29. Heyes M. P., Achim C., Wiley C. A., Major E. O., Saito K., and Markey S. P. (1996) Human microglia convert L-tryptophan to the neurotoxin quinolinic acid. Biochem. J. 320, 595-597.
30. Iadecola C., Xu X., Zhang F., El-Fakahany E. E., and Ross M. E. (1995) Marked induction of calcium-independent nitric oxide synthase activity after focal cerebral ischemia. J. Cereb. Blood Flow Metab. 15, 52-59.
31. Imamura K., Suzumura A., Sawada M., Marunouchi T., and Takahashi A. (1991) Functional and immunohistochemical studies of cultured rat microglia. Rinsho Shinkeigaku 31, 127-134.
32. Jorgensen M. B., Finsen B. R., Jensen M. B., Castellano B., Diemer N. H. A., and Zimmer J. (1993) Microglial and astroglial reactions to ischemic and kainic acid-induced lesions of the adult rat hippocampus. Exp. Neurol. 120, 70-88.
33. Kato H., Kogure K., Araki T., and Itoyama Y. (1995) Graded expression of immuno molecules on activated microglia in the hippocampus following ischemia in a rat model of ischemic tolerance. Brain Res. 694, 85-93.
34. Kawai K., Nitecka L., Ruetzler C. A., Nagashima G., Joó F., Mies G., Nowak T. S. Jr., Saito N., Lohr J., and Klatzo I. (1992) Global cerebral ischemia associated with cardiac arrest in the rat: I. Dynamics of early neuronal changes. J. Cereb. Blood Flow Metab. 12, 238-249.
35. Kemp J. A., Foster A. C., Leeson P. D., Priestley T., Tridgett R., Iverson L. L., and Woodruff G. N. (1988) 7-Chlorokynurenic acid is a selective antagonist at the glycine modulatory site of the N-methyl-D-aspartate receptor complex. Proc. Natl. Acad. Sci. USA 85, 6547-6550.
36. Kim J. P. and Choi D. W. (1987) Quinolinate neurotoxicity in cortical cell culture. Neuroscience 25, 423-432.
37. Kitagawa K., Matsumoto M., Ohtsuki T., Tagaya M., Okabe T., Hata R., Ueda H., Handa N., Sobue K., and Kamada T. (1992) The characteristics of blood-brain barrier in three different conditions - infarction, selective neuronal death and selective loss of presynaptic terminals-following cerebral ischemia. Acta Neuropathol. (Berl.) 84, 378-386.
38. Kochanek P. M. and Hallenbeck J. M. (1992) Polymorphonuclear leukocytes and monocytes/macrophages in the pathogenesis of cerebral ischemia and stroke. Stroke 23, 1367-1379.
39. Koshinaga M. and Whittemore S. R. (1995) The temporal and spatial activation of microglia in fibre tracts undergoing anterograde and retrograde degeneration following spinal cord lesion. J. Neurotrauma 12, 209-222.
40. Kuppusamy P., Ohnishi S. T., Numagami Y., Ohnishi T., and Zweier J. L. (1995) Three-dimensional imaging of nitric oxide production in the rat brain subjected to ischemia-hypoxia. J. Cereb. Blood Flow. Metab. 15, 899-903.
41. Kuroiwa T., Bonnekoh P., and Hossmann K.-A. (1990) Prevention of postischemic hyperthermia prevents ischemic injury of CA1 neurons in gerbils. J. Cereb. Blood Flow Metab. 10, 550-556.
42. McRae A., Bona E., and Hagberg H. (1996) Microglia-astrocyte interactions after cortisone treatment in a neonatal hypoxia-ischemia model. Brain Res. Dev. Brain Res. 94, 44-51.
43. Milstien S., Sakai N., Brew B. J., Krieger C., Vickers J. H., Saito K., and Heyes M. P. (1994) Cerebrospinal fluid nitrate/nitrite levels in neurologic diseases. J. Neurochem. 63, 1178-1180.
44. Moroni F., Russi P., Gallo-Mezo M. A., Moneti G., and Pellicciari R. (1991) Modulation of quinolinic acid and kynurenic acid content in the rat brain: effects of endotoxins and nicotinylalanine. J. Neurochem. 57, 1630-1635.
45. Mostardini M., Ferrario R. G., Caccia C., Speciale C., and Benatti L. (1996) Time-course of kynurenine-pathway enzyme mRNA levels upon interferon-γ in human monocyte/macrophages. Soc. Neurosci. Abstr. 22, 1794.
46. Naritsin D. B., Saito K., Markey S. P., Chen C. Y., and Heyes M. P. (1995) Metabolism of L-tryptophan to kynurenate and quinolinate in the central nervous system: effects of 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate. J. Neurochem. 65, 2217-2226.
47. Parli C. J., Krieter P., and Schmidt B. (1980) Metabolism of 6-chlorotryptophan to 4-chloro-3-hydroxyanthranilic acid: a potent inhibitor of 3-hydroxyanthranilic acid oxidase. Arch. Biochem. Biophys. 203, 161-166.
48. Popovich P. G., Reinhard J. F., Flanagan E. M., and Stokes B. T. (1994) Elevation of the neurotoxin quinolinic acid occurs following spinal cord trauma. Brain Res. 633, 348-352.
49. Pulsinelli W. A. and Duffy T. E. (1983) Regional energy balance in rat brain after transient forebrain ischemia. J. Neurochem. 40, 1500-1503.
50. Pulsinelli W. A., Brierley J. B., and Plum F. (1982) Temporal profile of neuronal damage in a model of transient forebrain ischemia. Ann. Neurol. 11, 491-498.
51. Robinson M. B., Heyes M. P., Anegawa N. J., Gorry E., Djali S., and Batshaw M. L. (1992) Quinolinate in brain and cerebrospinal fluid of rat models of congenital hyperammonemia. Pediatr. Res. 32, 483-488.
52. Saito K., Lackner A., Markey S. P., and Heyes M. P. (1991) Cerebral cortex and lung indoleamine-2,3-dioxygenase activity is increased in type-D retrovirus infected macaques. Brain Res. 540, 353-356.
53. Saito K., Markey S. P., and Heyes M. P. (1992) Effects of immune activation on quinolinic acid and kynurenine pathway metabolism in the mouse. Neuroscience 51, 25-39.
54. Saito K., Chen C. Y., Masana M., Crowley J., Markey S. P., and Heyes M. P. (1993a) 4-Chloro-3-hydroxyanthranilic acid, 6-chlorotryptophan and norharmane attenuate quinolinic acid formation by interferon-γ stimulated monocytes (THP-1) cells. Biochem. J. 291, 11-14.
55. Saito K., Crowley J. S., Markey S. P., and Heyes M. P. (1993b) A mechanism for increased quinolinic acid formation following acute systemic immune stimulation. J. Biol. Chem. 268, 15496-15503.
56. Saito K., Markey S. P., and Heyes M. P. (1993c) Cytokine and drug modulation of quinolinic acid synthesis by immune activated macrophages. Am. Soc. Cell Biol. M16.
57. Saito K., Nowak T. S. Jr., Markey S. P., and Heyes M. P. (1993d) Mechanism of delayed increases in kynurenine pathway metabolism in damaged brain regions following transient cerebral ischemia. J. Neurochem. 60, 180-192.
58. Saito K., Nowak T. S. Jr., Suyama K., Quearry B. J., Saito M., Crowley J. S., Markey S. P., and Heyes M. P. (1993e) Kynurenine pathway enzymes in brain: responses to ischemic brain injury versus systemic immune activation. J. Neurochem. 61, 2061-2070.
59. Saito K., Quearry B. J., Saito M., Nowak T. S., Markey S. P., and Heyes M. P. (1993f) Kynurenine-3-hydroxylase in brain: species activity differences and effect of gerbil cerebral ischemia. Arch. Biochem. Biophys. 307, 104-109.
60. Saito K., Markey S. P., and Heyes M. P. (1994) 6-Chloro-tryptophan, 4-chloro-3-hydroxyanthranilate and dexamethasone attenuate quinolinic acid accumulation in brain and blood following systemic immune activation. Neurosci. Lett. 178, 211-215.
61. Schwarcz R., Whetsell W. O., and Mangano R. E. M. (1983) Quinolinic acid: an endogenous metabolite can produce axon sparing lesions in rat brain. Science 219, 316-318.
62. Sedgewick J. D., Schwender S., Imrich H., Domes R., Butcher G. W., and ter Meulen Y. (1991) Isolation and direct characterization of resident microglial cells from the normal and inflamed central nervous system. Proc. Natl. Acad. Sci. USA 88, 7438-7442.
63. Smith M.-L., Auer R. N., and Siesjö B. K. (1984) The density and distribution of ischemic brain injury in the rat following 2-10 min of forebrain ischemia. Acta Neuropathol. (Berl.) 64, 319-332.
64. Speciale C. and Schwarcz R. (1993) On the production and disposition of quinolinic acid in rat brain and liver slices. J. Neurochem. 60, 212-218.
65. Stone T. W. (1993) Neuropharmacology of quinolinic and kynurenic acids. Pharmacol. Rev. 45, 309-379.
66. Taylor M. W. and Feng G. (1991) Relationship between interferon-γ, indoleamine-2,3-dioxygenase and tryptophan. FASEB J. 5, 2516-2522.
67. Thomas S. R., Mohr D., and Stocker R. (1994) Nitric oxide inhibits indoleamine 2,3-dioxygenase activity in interferon-gamma primed mononuclear phagocytes. J. Biol. Chem. 269, 14457-14464.
68. Whetsell W. O. and Schwarcz R. (1989) Prolonged exposure to submicromolar concentrations of quinolinic acid causes excitotoxic damage in organotypic cultures of rat corticostriatal system. Neurosci. Lett. 97, 271-275.
69. Zhang R. L., Chopp M., Garcia J. H., and Chen H. (1994) Temporal profile of ischemic tissue damage, neutrophil response, and vascular plugging following permanent and transient (2 h) middle cerebral artery occlusion in the rat. J. Neurol. Sci. 125, 3-10.